BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
BioAdaptives's gross profit for the twelve months ending Jun 30, 2026 was $19.79K, up 1761.4% year over year. For fiscal 2025 it was $12.50K, up 210.1% from the year before. The highest annual figure on record is $12.50K in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.50K | +210.1% |
| FY2024 | Dec 31, 2024 | $4.03K | -62.8% |
| FY2023 | Dec 31, 2023 | $10.82K | +51.8% |
| FY2022 | Dec 31, 2022 | $7.13K | -29.5% |
| FY2021 | Dec 31, 2021 | $10.11K | +65.8% |
| FY2020 | Dec 31, 2020 | $6.10K | +24.8% |
| FY2019 | Dec 31, 2019 | $4.89K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.24K | +298.9% |
| Q1 FY2026 | Mar 31, 2026 | $4.11K | – |
| Q4 FY2025 | Dec 31, 2025 | $7.58K | – |
| Q3 FY2025 | Sep 30, 2025 | $3.85K | – |
| Q2 FY2025 | Jun 30, 2025 | $1.06K | +147.8% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $429 | -71.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.60K | +81.9% |
| Q4 FY2023 | Dec 31, 2023 | $2.70K | +162.0% |
| Q3 FY2023 | Sep 30, 2023 | $4.65K | +132.5% |
| Q2 FY2023 | Jun 30, 2023 | $1.49K | -30.8% |
| Q1 FY2023 | Mar 31, 2023 | $1.98K | +1.9% |
| Q4 FY2022 | Dec 31, 2022 | $1.03K | -9.8% |
| Q3 FY2022 | Sep 30, 2022 | $2.00K | -35.8% |
| Q2 FY2022 | Jun 30, 2022 | $2.15K | -35.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.94K | -22.2% |
| Q4 FY2021 | Dec 31, 2021 | $1.14K | -28.8% |
| Q3 FY2021 | Sep 30, 2021 | $3.12K | +196.4% |
| Q2 FY2021 | Jun 30, 2021 | $3.35K | +2180.3% |
| Q1 FY2021 | Mar 31, 2021 | $2.50K | -24.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.60K | – |
| Q3 FY2020 | Sep 30, 2020 | $1.05K | -36.0% |
| Q2 FY2020 | Jun 30, 2020 | $147 | -96.0% |
| Q1 FY2020 | Mar 31, 2020 | $3.29K | +176.3% |
| Q4 FY2019 | Dec 31, 2019 | -$1.64K | -126.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.64K | – |
| Q2 FY2019 | Jun 30, 2019 | $3.69K | – |
| Q1 FY2019 | Mar 31, 2019 | $1.19K | – |
| Q3 FY2016 | Sep 30, 2016 | $6.11K | – |
See a number that looks wrong?